These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8561139)

  • 21. p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.
    Russo A; Migliavacca M; Zanna I; Valerio MR; Latteri MA; Grassi N; Pantuso G; Salerno S; Dardanoni G; Albanese I; La Farina M; Tomasino RM; Gebbia N; Bazan V
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1322-31. PubMed ID: 12433709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Over-expression of p53 protein in neoplastic changes in ulcerative colitis: immunohistochemical study.
    Ajioka Y; Watanabe H; Matsuda K
    J Gastroenterol; 1995 Nov; 30 Suppl 8():33-5. PubMed ID: 8563884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genome analyses for precancerous lesions in the gastrointestinal tract].
    Sowa M; Nakata B
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):335-40. PubMed ID: 10740625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [p53 and colorectal cancer].
    Hamelin R; Laurent-Puig P
    Pathol Biol (Paris); 1997 Dec; 45(10):876-81. PubMed ID: 9769952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of p53 and bcl-2 in colorectal adenomas and carcinomas].
    Sundblad AS; Chumbita RL; Zoppi JA
    Medicina (B Aires); 1997; 57(6):662-6. PubMed ID: 9674186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
    Brüwer M; Schmid KW; Senninger N; Schürmann G
    World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma.
    Kahlenberg MS; Stoler DL; Rodriguez-Bigas MA; Weber TK; Driscoll DL; Anderson GR; Petrelli NJ
    Cancer; 2000 Apr; 88(8):1814-9. PubMed ID: 10760757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Genetic alterations leading to the development of colitis-associated colorectal cancers].
    Marusawa H; Takai A; Chiba T
    Nihon Rinsho; 2012 Feb; 70 Suppl 1():651-5. PubMed ID: 23126168
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased risk of colorectal adenomas in Italian subjects carrying the p53 PIN3 A2-Pro72 haplotype.
    Perfumo C; Bonelli L; Menichini P; Inga A; Gismondi V; Ciferri E; Percivale P; Bianchi Scarrà G; Nasti S; Fronza G; Varesco L
    Digestion; 2006; 74(3-4):228-35. PubMed ID: 17374954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of telomerase and its hTERT messenger in colorectal cancer.
    Boldrini L; Faviana P; Gisfredi S; Donati V; Zucconi Y; Ursino S; Simi P; Baldinotti F; Berti P; Galleri D; Materazzi G; Basolo F; Miccoli P; Pingitore R; Fontanini G
    Oncol Rep; 2004 Feb; 11(2):395-400. PubMed ID: 14719074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis.
    Esteller M; Risques RA; Toyota M; Capella G; Moreno V; Peinado MA; Baylin SB; Herman JG
    Cancer Res; 2001 Jun; 61(12):4689-92. PubMed ID: 11406538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic alterations and molecular mechanisms underlying colorectal tumorigenesis].
    Ronchetto F
    Minerva Med; 1998 May; 89(5):163-8. PubMed ID: 9676181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genes of micrometastasis in bone marrow of patients with colorectal cancer].
    Li S; Luo C; Yu B; Yuan S; Liang Z
    Zhonghua Wai Ke Za Zhi; 2000 Mar; 38(3):196-7. PubMed ID: 11832027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics of colorectal polyps.
    Molatore S; Ranzani GN
    Tech Coloproctol; 2004 Dec; 8 Suppl 2():s240-2. PubMed ID: 15666098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [p53 mutations and protein overexpression in primary colorectal cancer and its liver metastasis].
    Yang Y; Xia Q; Lian F
    Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):114-8. PubMed ID: 11776850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
    Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.
    Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL
    Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic relevance of p53 mutation in colorectal carcinoma.
    Ofner D; Schmid KW P
    Gastroenterology; 1994 Nov; 107(5):1571-2. PubMed ID: 7926526
    [No Abstract]   [Full Text] [Related]  

  • 39. Colorectal cancer: A circuitous way to target p53.
    Seton-Rogers S
    Nat Rev Cancer; 2015 Jun; 15(6):318-9. PubMed ID: 25971675
    [No Abstract]   [Full Text] [Related]  

  • 40. Cancer: An essential passenger with p53.
    Bradner JE
    Nature; 2015 Apr; 520(7549):626-7. PubMed ID: 25901678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.